×
khaskhabar
Nov 20, 2026 6:13 am
Location
 
   राजस्थान और हरियाणा सरकार से विज्ञापनों के लिए मान्यता प्राप्त

Kidney Drug Found Effective in Treating Infertility, Study Finds



www.khaskhabar.com | Published : 10-02-2026

Kidney Drug Found Effective in Treating Infertility, Study Finds


New Delhi, A drug commonly used to treat chronic kidney disease and heart failure has been found to be effective in treating premature ovarian insufficiency, offering new hope in infertility treatment, according to a study by a team of scientists. The research, conducted by scholars from Juntendo University in Japan and the University of Hong Kong, was published on Tuesday in the electronic edition of the American journal Science. The researchers believe the discovery could pave the way for a new therapeutic approach to infertility. Speaking to The Japan Times, Professor Kazuhiro Kawamura of Juntendo University said, “We want to optimize ovarian stimulation and discover more effective drugs.” Premature ovarian insufficiency is a condition in which women stop having menstrual periods before the age of 40. Although the condition involves ovarian fibrosis, which inhibits follicle growth, the drug finerenone is known to suppress fibrosis in kidney and heart tissue. In a clinical trial, the research team administered finerenone to patients with premature ovarian insufficiency, along with drugs used for ovarian stimulation and ovum maturation. As a result, a fertilized egg was obtained through in vitro fertilization (IVF). Prior to the clinical trial, the team conducted experiments on mice to determine whether finerenone could promote follicle growth. The results showed that mice given the drug produced more offspring than normal, with no abnormalities observed in the newborns. In 2013, Professor Kawamura, who was then an associate professor at St. Marianna University School of Medicine, introduced an infertility treatment method known as “in vitro activation.” This method, now used clinically, involves collecting a portion of a patient’s ovary via laparoscopy, activating follicles using medical agents, and transplanting them beneath the ovarian membrane. However, the procedure requires general anesthesia, which is not always suitable for patients. The research team therefore sought an oral drug that could produce similar effects. After testing approximately 1,300 drugs, finerenone was identified as the most suitable option. The findings are expected to contribute significantly to the development of less invasive and more effective infertility treatments in the future.